At B-Secur, we’ve always believed that our future is only as bright as our people, so we’re delighted with the news that our Chief Scientific Officer Alan Kennedy has formally received his PhD from the University of Ulster.
Alan is an award-winning researcher in biomedical/medical engineering, with accolades including First Prize in the Young Investigator Competition from the Stafford Warren Symposium on Myocardial Ischemia and the John RE Scott Postgraduate Student of the Year from the University of Ulster, recognising academic achievement.
We caught up with Alan to learn more about his passion for the subject, what he is currently focused on in B-Secur and why scientific credibility is crucial for young tech businesses.
Congratulations on your doctoral conferment Alan! Do we have to call you Dr Alan from now on?
"Thanks, and yes, I am currently working internally to ensure this is stated in our employee handbook and enforced across the company!"
Tell us more about your PhD subject, and about your doctoral thesis.
"My doctorate was on the automated computerised detection of cardiac arrhythmias from the electrocardiogram. My work focusing on an arrhythmia called Atrial Fibrillation which is difficult to detect from the ECG and if left untreated is one of the leading causes of strokes worldwide."
You’re currently B-Secur’s Chief Scientific Officer. How would you describe what you do for the business?
"As B-Secur’s Chief Scientific Officer I am responsible for the scientific strategy of the company along with the scientific research and development of our ECG algorithms."
Have you always had an interest in biomedical engineering?
"From a young age I can remember being interested in technology, but it wasn’t until I reached university did I realise I could apply my interest for technology to the medical field to develop new medical devices and technology."